Dexamethasone to combat cytokine storm in COVID-19: Clinical trials and preliminary evidence
- PMID: 32896649
- PMCID: PMC7472975
- DOI: 10.1016/j.ijsu.2020.08.038
Dexamethasone to combat cytokine storm in COVID-19: Clinical trials and preliminary evidence
Keywords: COVID-19; Clinical trials; Cytokine storm; Dexamethasone; SARS-CoV-2; Therapeutics.
Conflict of interest statement
All authors declare that there exist no commercial or financial relationships that could, in any way, lead to a potential conflict of interest.
References
-
- Abdolahi N., Kaheh E., Golsha R., et al. Letter to the editor: efficacy of different methods of combination regimen administrations including dexamethasone, intravenous immunoglobulin, and interferon-beta to treat critically ill COVID-19 patients: a structured summary of a study protocol for a randomized controlled trial. Trials. 2020 Jun 19;21(1):549. doi: 10.1186/s13063-020-04499-5. - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous